Increase in gentamicin uptake by cultured mouse peritoneal macrophages and rat hepatocytes by its binding to polybutylcyanoacrylate nanoparticles

International Journal of Pharmaceutics

Volumn 164, Issue 1-2, 1998, Pages 21-27

  Zhang, Qiang ^a   Liao, Gongtie ^b   Wei, Dapen ^b   Nagai, T ^c  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b SICHUAN UNIVERSITY   (China)

^c HOSHI UNIVERSITY   (Japan)

Author keywords

Gentamicin; In vitro cell uptake; Mouse peritoneal macrophages; Nanoparticles; Rat hepatocytes

Indexed keywords

ENBUCRILATE; GENTAMICIN; NANOPARTICLE; STABILIZING AGENT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG BINDING AND TRANSPORT; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG UPTAKE; IN VITRO STUDY; LIVER CELL; MOUSE; NONHUMAN; PARTICLE SIZE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT;

EID: 0032513529     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00395-5     Document Type: Article

References (13)

1. Brajtburg J., Powderly W.G., Kobayashi G.S., Medoff G. Amphotericin B: delivery systems. Antimicrob. Agents Chemother. 34:1990;381-384.
2. Couvreur P., Tulkens P., Rolland M., Trouet A., Speiser P. Nanoparticles: a new type of lysosomotropic carrier. FEBS Lett. 84:1977;323-326.
3. Fattal E., Rojas J., Roblot-Treupel L., Andremont A., Couvreur P. Ampicillin-loaded liposomes and nanoparticles: comparison of drug loading, drug release and in vitro antimicrobial activity. J. Microencapsulation. 8:1991;29-36.
4. Fattal E., Youssef M., Couvreur P., Andremont A. Treatment of experimental Sallmonellosis in mice with ampicillin-bound nanoparticles. Antimicrob. Agents Chemother. 33:1989;1540-1543.
5. Johnson J.D., Hand W.L., Francis J.B., King-Thompson N., Corwin R.W. Antibiotic uptake by alveolar macrophages. J. Lab. Clin. Med. 95:1980;429-439.
6. Kaneo Y., Tanaka T., Fujihara Y., Mori H., Iguch S. Delivery of glutathione, as a dextran conjugate, into the liver. Int. J. Pharm. 44:1988;265-267.
7. Kreuter J. Evaluation of nanoparticles as drug delivery systems. II. Comparison of the body distribution of nanoparticles with the body distribution of microspheres (diameter <1 μm), liposome and emulsions. Pharm. Acta Helv. 58:1983;217-226.
8. Lenaerts V., Nagelkerke J.F., van Berkel T.J.C. et al. In vitro uptake of polyisobutylcyanoacrylate nanoparticles by rat liver Kupffer, endothelial and parenchymal cells. J. Pharm. Sci. 73:1984;980-983.
9. Trouet A., Tulkens P. Intracellular penetration and distribution of antibiotics: the basis for an improved chemotherapy of intracellular infections. Ninet L., Bost P.E., Bouanchand D.H., Lorent J. The Future of Antibiotherapy and Antibiotic Research. 1981;337-349 Academic Press, London.
10. Tulkens P. The design of antibiotics capable of an intracellular action. Buri P., Gumma R. Aims, Potentialities and Problems in Drug Targeting. 1985;179-194 Elsevier, Amsterdam.
11. Youssef M., Jattal E., Alonso M.J. et al. Effectiveness of nanoparticle bound ampicillin in athymic nude mice. Antimicrob. Agents Chemother. 32:1988;1204-1207.
12. Zhang Q., Liao G.T. Preparation techniques of gentamicin polybutylcyanoacrylate nanoparticles. Chin. Pharm. J. 31:1996;24-27.
13. Zhang Q., Liao G.T., Shou D. The electricity properties of polybutylcyanoacrylate nanoparticles. J. West China Univ. Med. Sci. 27:1996;400-404.